Tuesday, July 31, 2007

Big Tobacco and Big Pharma unite

Researchers have started a project with the aim of creating another vaccine for cervical cancer. They are working to extract a substance from the tobacco plant that could be used in a new vaccine that would prevent cervical cancer. Researchers from the University of Louisville who helped invent Gardasil, Dr. A. Bennett Jenson and Shin-je Ghim, are also working on this new project. The primary difference between the two vaccines is the cost.

The new vaccine will cost $3 dollar for three doses, while the cost of three doses of Gardasil is $360. This would make it affordable for developing countries like India, where the disease is the most common malignancy among women.

COMMENT: There can be little doubt that the tobacco industry will get a huge boost from this research too. If they are insisting on a cervical cancer vaccine, at least this one would gut the profits from Merck...that is, if it would be available in the US. Looks like they are making this vaccine for third world countries. Merck may not allow it to be approved here so it can keep its massive profits intact.

Instead of the vaccine, there is an easier, more natural way, to fight cervical cancer.

In a placebo-controlled human trial, 200 mg/day I3C, a readily available supplement from extracted cruciferous vegetables, resulted in complete regression of cervical precancerous growth in four of eight patients, and 400 mg/day resulted in complete regression in four of nine patients. In the placebo group, none of the patients had complete regression. Results indicate that I3C has potential therapeutic affects against HPV-induced growths in the cervix. (Reference: PMID: 10926790 ) These were small studies, but there are many other articles in PubMed that identify I3C and DIM as molecules that can prevent cervical (and breast) cancer.


DIM, like I3C, is present in broccoli, cabbage, cauliflower, Brussels sprouts, and Chinese cabbage. Each DIM is formed from the combining of two I3C molecules. In some studies in which I3C was fed to animals, about 4% of what left the stomach turned into DIM. The problem with I3C is unstable, has a very short shelf life, and the product breaks down into inactive metabolites. DIM is has a stable shelf life and is the reason it is a better supplement.

Bottom line: Cervical cancer may be a nutritional deficiency, especially in Third-World countries. No vaccine is needed at all.

0 comments: